These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12171388)

  • 1. 5-HT1A dysfunction in borderline personality disorder.
    Hansenne M; Pitchot W; Pinto E; Reggers J; Scantamburlo G; Fuchs S; Pirard S; Ansseau M
    Psychol Med; 2002 Jul; 32(5):935-41. PubMed ID: 12171388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior.
    Pitchot W; Hansenne M; Pinto E; Reggers J; Fuchs S; Ansseau M
    Biol Psychiatry; 2005 Dec; 58(11):854-8. PubMed ID: 16139805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior.
    Pitchot W; Ansseau M; Gonzalez Moreno A; Lembreghts M; Hansenne M; Wauthy J; Reel C; Jammaer R; Papart P; Sulon J
    Pharmacopsychiatry; 1995 Oct; 28 Suppl 2():91-2. PubMed ID: 8614706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic sensitivity in borderline personality disorder: preliminary findings.
    Hollander E; Stein DJ; DeCaria CM; Cohen L; Saoud JB; Skodol AE; Kellman D; Rosnick L; Oldham JM
    Am J Psychiatry; 1994 Feb; 151(2):277-80. PubMed ID: 8296905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and psychiatric comorbidities of borderline personality disorder patients with versus without a history of suicide attempt.
    Sher L; Fisher AM; Kelliher CH; Penner JD; Goodman M; Koenigsberg HW; New AS; Siever LJ; Hazlett EA
    Psychiatry Res; 2016 Dec; 246():261-266. PubMed ID: 27728869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients.
    Rinne T; Westenberg HG; den Boer JA; van den Brink W
    Biol Psychiatry; 2000 Mar; 47(6):548-56. PubMed ID: 10715361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder.
    Soloff PH; Kelly TM; Strotmeyer SJ; Malone KM; Mann JJ
    Psychiatry Res; 2003 Jul; 119(1-2):11-24. PubMed ID: 12860356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.
    Soloff PH; Chiappetta L; Mason NS; Becker C; Price JC
    Psychiatry Res; 2014 Jun; 222(3):140-8. PubMed ID: 24751216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls.
    Paris J; Zweig-Frank H; Kin NM; Schwartz G; Steiger H; Nair NP
    Psychiatry Res; 2004 Jan; 121(3):239-52. PubMed ID: 14675743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H; Sjögren M; Agren H
    J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal and temperature responses to the 5-HT1A receptor agonist flesinoxan in normal volunteers.
    Pitchot W; Wauthy J; Hansenne M; Pinto E; Fuchs S; Reggers J; Legros JJ; Ansseau M
    Psychopharmacology (Berl); 2002 Oct; 164(1):27-32. PubMed ID: 12373416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Should hospitalization be required after the emergency discharge of patients with borderline personality disorder who have attempted suicide (FRENCH CRISIS cohort)?].
    Cailhol L; Riedi G; Mathur A; Czapla P; Charpentier S; Genestal M; Birmes P
    Encephale; 2014 Sep; 40(4):289-94. PubMed ID: 24815791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine evaluation of 5-HT1A function in male alcoholic patients.
    Pinto E; Reggers J; Pitchot W; Hansenne M; Fuchs S; Ansseau M
    Psychoneuroendocrinology; 2002 Oct; 27(7):873-9. PubMed ID: 12183221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study.
    Pitchot W; Wauthy J; Legros JJ; Ansseau M
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder.
    Oquendo MA; Krunic A; Parsey RV; Milak M; Malone KM; Anderson A; van Heertum RL; John Mann J
    Neuropsychopharmacology; 2005 Jun; 30(6):1163-72. PubMed ID: 15770239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between the frequency and severity of non-suicidal self-injury and suicide attempts in youth with borderline personality disorder.
    Andrewes HE; Hulbert C; Cotton SM; Betts J; Chanen AM
    Early Interv Psychiatry; 2019 Apr; 13(2):194-201. PubMed ID: 28718985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressiveness, not impulsiveness or hostility, distinguishes suicide attempters with major depression.
    Keilp JG; Gorlyn M; Oquendo MA; Brodsky B; Ellis SP; Stanley B; John Mann J
    Psychol Med; 2006 Dec; 36(12):1779-88. PubMed ID: 16959059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpersonal precipitants and suicide attempts in borderline personality disorder.
    Brodsky BS; Groves SA; Oquendo MA; Mann JJ; Stanley B
    Suicide Life Threat Behav; 2006 Jun; 36(3):313-22. PubMed ID: 16805659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the contribution of borderline personality disorder and features to suicide risk in psychiatric inpatients with bipolar disorder, major depression and schizoaffective disorder.
    Zeng R; Cohen LJ; Tanis T; Qizilbash A; Lopatyuk Y; Yaseen ZS; Galynker I
    Psychiatry Res; 2015 Mar; 226(1):361-7. PubMed ID: 25661531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep-EEG in borderline patients without concomitant major depression: a comparison with major depressives and normal control subjects.
    De la Fuente JM; Bobes J; Vizuete C; Mendlewicz J
    Psychiatry Res; 2001 Dec; 105(1-2):87-95. PubMed ID: 11740978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.